Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ansuman T. Satpathy"'
Autor:
Zinaida Good, Crystal L. Mackall, Dorota Klysz, Yanyan Qi, John Lattin, Louai Labanieh, Katalin Sandor, Bence Daniel, Howard Y. Chang, Peng Xu, Ansuman T. Satpathy, Thomas J. Wandless, Panayiotis Vandris, Elena Sotillo, Meena Malipatlolla, Ling-chun Chen, Andrew J. Gentles, Rachel C. Lynn, Sabine Heitzeneder, Hima Anbunathan, Evan W. Weber, Kevin R. Parker, Malek Bashti, Snehit Prabhu, Robbie G. Majzner, Julia A. Belk
Publikováno v:
Science (New York, N.Y.)
CAR-T cells rest to get back in the race Chimeric antigen receptor (CAR)–T cells, which are engineered to target specific tumor antigens, are increasingly used as an immunotherapy. CAR-T cells have shown promising results in patients, particularly
Autor:
Neil E. Wilson, Aparna Bhaduri, Fang Liu, Ansuman T. Satpathy, Howard Y. Chang, Eric Perkey, Khatuna Gabunia, John Scholler, Ivan Maillard, Thomas J. Montine, Arnold R. Kriegstein, Avery D. Posey, Vijay Bhoj, Denis Migliorini, Ravinder Reddy, Carl H. June, Mohammad Haris, Kevin R. Parker, Puneet Bagga, Kathryn E. Yost, Suyash Mohan
Publikováno v:
Cell, Vol. 183, No 1 (2020) pp. 126-142.e17
Cell, vol 183, iss 1
Cell
Cell, vol 183, iss 1
Cell
CD19-directed immunotherapies are clinically effective for treating B cell malignancies but also cause a high incidence of neurotoxicity. A subset of patients treated with chimeric antigen receptor (CAR) Tcells or bispecific Tcell engager (BiTE) anti